Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects-Reference-Cited by-同舟云学术

Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects

Published:2007-05-30 Issue:9 Volume:35 Page:1543-1553
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Hoffmann Matthew,DeMaio William,Jordan Ronald A.,Talaat Rasmy,Harper Dawn,Speth John,Scatina JoAnn

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference21 articles.

1. Identification and determination of the two principal metabolites of minocycline in humans

2. Pharmacokinetics in the interpretation of chronic toxicity tests: The last-in, first-out phenomenon

3. In-vitro activity of two glycylcyclines against enterococci resistant to other agents

4. Jusko WJ (1992) Guidelines for collection and analysis of pharmacokinetic data, in Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, 3rd ed (Evans WE, Schentag JJ, and Jusko WJ eds) pp 2-1-2-43. Applied Therapeutics, Vancouver.

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models;Microbiology Spectrum;2024-01-11

2. Predicting bioactivity of antibiotic metabolites by molecular docking and dynamics;Journal of Molecular Graphics and Modelling;2023-09

3. Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia;Infection and Drug Resistance;2023-09

4. Bioavailability of tetracyclines is substantially increased by administration of cyclosporine A, a non-specific efflux-pump blocker;Drug Metabolism and Pharmacokinetics;2023-06

5. Tigecycline Immunodetection Using Developed Group-Specific and Selective Antibodies for Drug Monitoring Purposes;Biosensors;2023-03-04